NCT07491445
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07491445
Title Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma (RASolute 303)
Acronym RASolute 303
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Revolution Medicines, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Honor Health Research Institute RECRUITING Scottsdale Arizona 85258 United States Details
H Lee Moffitt Cancer Center and Research Institute RECRUITING Tampa Florida 33612 United States Details
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center RECRUITING Baltimore Maryland 21287 United States Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Comprehensive Cancer Centers of Nevada RECRUITING Henderson Nevada 89052 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
University of Cincinnati Cancer Center RECRUITING Cincinnati Ohio 45219 United States Details
Taylor Cancer Research Center RECRUITING Maumee Ohio 43537 United States Details
SCRI Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
SCRI - Texas Oncology Dallas RECRUITING Dallas Texas 95246 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
Virginia Cancer Specialists RECRUITING Fairfax Virginia 22031 United States Details
Virginia Mason Medical Center RECRUITING Seattle Washington 98101 United States Details
Calvary Mater Newcastle RECRUITING Waratah New South Wales 2298 Australia Details
National Cancer Center - East RECRUITING Kashiwa Chiba 277-8577 Japan Details
Cancer Institute Hospital - Japan Foundation for Cancer Research RECRUITING Koto-Ku Tokyo 135-8550 Japan Details
NHO Kyushu Cancer Center RECRUITING Fukuoka 811-1395 Japan Details
Kanagawa Cancer Canter RECRUITING Kanagawa 241-0815 Japan Details
Wakayama Medical University Hospital RECRUITING Wakayama 641-8510 Japan Details
Yamaguchi University Hospital RECRUITING Yamaguchi 755-8505 Japan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field